Canadian institutes team up to develop new imaging agents

05/4/2009 | HealthImaging.com

MDS Nordion, the University of British Columbia and TRIUMF -- Canada's facility for particle and nuclear physics -- have reached a three-year agreement to develop new diagnostic imaging agents using a class of medical isotopes called radiometals and chelates, which are substances that bind to and protect radiometals when inside the body. The partnership aims to use the agents in the detection and treatment of cancer and heart disease.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY